For Korean stock market news & analysis, Click Here

[Feb 04, 2026] US Pre-market: Eli Lilly & SMCI Earnings Surge; Nvidia's OpenAI Move

Feb 4: Eli Lilly & SMCI crush earnings. NVDA reportedly invests $20B in OpenAI. PayPal downgraded. Full pre-market analysis of key U.S. stocks.

 

■ AI & Semiconductor Leaders

Nvidia (NVDA)

  • Reports indicate Nvidia is expected to invest $20 billion in OpenAI.

  • Despite previous rumors of hesitation, CEOs Jensen Huang and Sam Altman denied such claims, confirming Nvidia's participation in the funding round.

  • While this marks Nvidia's largest single investment in OpenAI to date, it falls significantly short of the $100 billion maximum discussed back in September.

AMD (AMD)

  • Q4 revenue reached $10.27 billion, beating the $9.67 billion forecast, while adjusted EPS of $1.53 surpassed the $1.32 estimate.

  • Q1 2026 revenue guidance was set at approximately $9.8 billion, exceeding the $9.38 billion expectation.

  • However, shares are reflecting disappointment as some analysts had anticipated even stronger guidance amid the ongoing AI processor spending boom.

Super Micro Computer (SMCI)

  • Fueled by intense demand for AI-optimized servers, SMCI reported a massive Q2 beat.

  • Adjusted EPS hit $0.69 (vs. $0.49 est), and revenue reached $12.68 billion (vs. $10.23B est).

  • The company raised its FY2026 revenue guidance to at least $40 billion.


■ Healthcare & Biotechnology

Eli Lilly (LLY)

  • Reported stellar Q4 adjusted EPS of $7.54 on revenue of $19.29 billion, crushing estimates of $6.67 and $17.96B, respectively.

  • For 2026, Lilly projects revenue between $80 billion and $83 billion, well above the $77.62B consensus.

  • Annual adjusted EPS guidance was set at $33.50–$35.00, topping the $33.23 market estimate.

Novo Nordisk (NVO)

  • Q4 results were solid with an adjusted EPS of $1.02 and revenue of $12.53 billion, beating expectations.

  • However, the stock faces pressure after the company projected 2026 revenue and operating profit to decrease by 5% to 13%.

  • Barclays noted this may be a "reset" to clear negative news, similar to concerns seen last year that did not materialize.

GE Healthcare (GEHC)

  • Q4 adjusted EPS reached $1.44 on revenue of $5.7 billion, both beating estimates.

  • Issued strong 2026 adjusted EPS guidance of $4.95–$5.15, representing 7.9%–12.3% growth.


■ Fintech & Consumer Services

PayPal (PYPL)

  • Canaccord downgraded PayPal to Hold, citing fading e-commerce competitiveness and pressure from Apple/Google Pay.

  • HSBC also lowered its rating to Hold ($47 PT) due to a sharp slowdown in branded payment volume in Q4.

  • Citizens downgraded to Neutral, warning that "agentic commerce" is increasing competitive risks and causing market share loss.

Booking Holdings (BKNG)

  • Mizuho Securities upgraded to Outperform ($6,000 PT), suggesting AI fears are exaggerated.

  • Analyst noted that during the 2018 shift to meta-search, Online Travel Agencies (OTAs) actually gained market share.

  • Projected 19% growth in 2026 adjusted EPS also supports the bullish outlook.


■ Retail Sector Pivot

Walmart (WMT) & PepsiCo (PEP)

  • Jefferies anticipates widespread price cuts across the sector, favoring Walmart.

  • PepsiCo announced price reductions of up to 15% on Lay's and Doritos to combat volume stagnation and competition from private labels.

  • Walmart is seen as the winner due to superior pricing power and its recent milestone of surpassing a $1 trillion market cap.


■ Key Mid-Cap & Sector Updates

  • ■ Enphase Energy (ENPH): Shares surged on optimistic Q1 revenue guidance of $270M–$300M.

  • ■ Silicon Laboratories (SLAB): Surged after Texas Instruments (TXN) agreed to acquire the company for $7.5 billion.

  • ■ Quantum Computing (QUBT): Completed the $110M cash acquisition of Lumina Semiconductor to speed up commercialization.

  • ■ Boston Scientific (BSX): Plunged 9% after providing disappointing annual guidance.

  • ■ Varonis Systems (VRNS): Dropped as 2026 EPS guidance ($0.06–$0.10) missed the $0.35 consensus.

  • ■ Take-Two (TTWO): Rose after raising 2026 net bookings guidance to $6.65B–$6.7B.



In Be Stock. Expert U.S. market news, trending stock analysis, and essential investor education. The best way to stay in the best stocks.

Post a Comment

New comments are not allowed.